• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坦索罗辛代谢物对α-1肾上腺素能受体亚型的作用。

Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.

作者信息

Taguchi K, Saitoh M, Sato S, Asano M, Michel M C

机构信息

Department of Medicine, University of Essen, Germany.

出版信息

J Pharmacol Exp Ther. 1997 Jan;280(1):1-5.

PMID:8996174
Abstract

We have investigated the affinity and selectivity of tamsulosin and its metabolites, M1, M2, M3, M4 and AM1, at the tissue and the cloned alpha-1 adrenoceptor subtypes in the radioligand binding and the functional studies. In the radioligand binding studies, the compounds competed for [3H]prazosin binding to the rat liver and kidney alpha-1 adrenoceptors, with the rank order of potency tamsulosin approximately M4 > M1 > M2 approximately M3 > > AM1 with the latter having a negligible affinity. All compounds differentiated cloned alpha-1 adrenoceptor subtypes with the rank order of potency of alpha-1A > or = alpha-1D > alpha-1B, except for M4 which had the highest affinity for the alpha-1D adrenoceptor. The compounds also concentration-dependently antagonized phenylephrine-induced contractions in the rabbit aorta and prostate. The resulting apparent pA2 values were very similar to those at the cloned rat alpha-1A adrenoceptor. We conclude that most tamsulosin metabolites are high potency antagonists at the alpha-1 adrenoceptors and retain the alpha-1A over the alpha-1B adrenoceptor selectivity of tamsulosin.

摘要

我们在放射性配体结合和功能研究中,研究了坦索罗辛及其代谢产物M1、M2、M3、M4和AM1在组织及克隆的α-1肾上腺素能受体亚型上的亲和力和选择性。在放射性配体结合研究中,这些化合物竞争[3H]哌唑嗪与大鼠肝脏和肾脏α-1肾上腺素能受体的结合,效力顺序为坦索罗辛约M4 > M1 > M2约M3 > > AM1,后者的亲和力可忽略不计。除M4对α-1D肾上腺素能受体具有最高亲和力外,所有化合物对克隆的α-1肾上腺素能受体亚型的区分效力顺序为α-1A≥α-1D > α-1B。这些化合物还能浓度依赖性地拮抗苯肾上腺素诱导的兔主动脉和前列腺收缩。所得的表观pA2值与克隆的大鼠α-1A肾上腺素能受体上的值非常相似。我们得出结论,大多数坦索罗辛代谢产物是α-1肾上腺素能受体的高效拮抗剂,并保留了坦索罗辛对α-1A肾上腺素能受体相对于α-1B肾上腺素能受体的选择性。

相似文献

1
Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.坦索罗辛代谢物对α-1肾上腺素能受体亚型的作用。
J Pharmacol Exp Ther. 1997 Jan;280(1):1-5.
2
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.α1肾上腺素能受体拮抗剂在前列腺α1肾上腺素能受体上的药理选择性概况评估:结合、功能及体内研究
Br J Pharmacol. 1996 Jun;118(4):871-8. doi: 10.1111/j.1476-5381.1996.tb15480.x.
3
The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.坦索罗辛(一种对功能性α1A - 和α1D - 肾上腺素能受体亚型具有高亲和力的拮抗剂)的作用。
Br J Pharmacol. 1997 Jan;120(2):231-8. doi: 10.1038/sj.bjp.0700907.
4
Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.豚鼠、牛和大鼠α1肾上腺素能受体亚型的比较。
Br J Pharmacol. 1996 Feb;117(4):703-11. doi: 10.1111/j.1476-5381.1996.tb15247.x.
5
Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.α-1肾上腺素能受体拮抗剂的比较性α-1肾上腺素能受体亚型选择性和功能性尿选择性
J Pharmacol Exp Ther. 1997 Jul;282(1):228-35.
6
RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.RS - 17053(N - [2 - (2 - 环丙基甲氧基苯氧基)乙基]-5 - 氯 - α,α - 二甲基 - 1H - 吲哚 - 3 - 乙胺盐酸盐),一种选择性α1A - 肾上腺素能受体拮抗剂,对人前列腺中的功能性α1 - 肾上腺素能受体显示出低亲和力:对肾上腺素能受体分类的意义。
Mol Pharmacol. 1996 Feb;49(2):209-15.
7
RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.RBx 6198:一种用于治疗良性前列腺增生的新型α1肾上腺素能受体拮抗剂。
Eur J Pharmacol. 2009 Apr 1;607(1-3):213-9. doi: 10.1016/j.ejphar.2009.02.026. Epub 2009 Feb 23.
8
Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.大鼠肾单位各节段间α1-肾上腺素能受体亚型的异质性表达。
Mol Pharmacol. 1993 Nov;44(5):926-33.
9
An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.四种新型α(1a)-肾上腺素能受体亚型选择性拮抗剂的尿选择性特性研究。
J Pharmacol Exp Ther. 2000 Jul;294(1):224-9.
10
Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.新型选择性α1-肾上腺素能受体拮抗剂KMD-3213的药理学分析及其作为氚标记放射性配体的适用性
Br J Pharmacol. 1999 May;127(1):19-26. doi: 10.1038/sj.bjp.0702489.

引用本文的文献

1
Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery.α-肾上腺素能拮抗剂与虹膜动力学:白内障手术中的挑战与解决方案。
BMC Ophthalmol. 2024 Oct 3;24(1):431. doi: 10.1186/s12886-024-03705-1.
2
Measurement of tamsulosin in human serum by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法测定人血清中的坦索罗辛。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jul 1;930:121-8. doi: 10.1016/j.jchromb.2013.04.020. Epub 2013 Apr 19.
3
Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin.
强 CYP2D6 和 3A4 抑制剂帕罗西汀和酮康唑对坦索罗辛药代动力学和心血管安全性的影响。
Br J Clin Pharmacol. 2011 Aug;72(2):247-56. doi: 10.1111/j.1365-2125.2011.03988.x.
4
α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.α1-肾上腺素能受体和毒蕈碱受体在排尿功能中的作用——治疗药物的结合特性与药代动力学的关系。
Br J Clin Pharmacol. 2011 Aug;72(2):205-17. doi: 10.1111/j.1365-2125.2011.03922.x.
5
Population pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladder.盐酸坦索罗辛在神经原性和非神经原性膀胱患儿中的群体药代动力学。
Br J Clin Pharmacol. 2010 Jul;70(1):88-101. doi: 10.1111/j.1365-2125.2010.03662.x.
6
Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations.坦索罗辛控释和口服控释系统制剂的药代动力学和药效学。
Clin Pharmacokinet. 2010 Mar;49(3):177-88. doi: 10.2165/11317580-000000000-00000.
7
Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.膀胱、尿道和前列腺中的α1、α2和β肾上腺素能受体。
Br J Pharmacol. 2006 Feb;147 Suppl 2(Suppl 2):S88-119. doi: 10.1038/sj.bjp.0706619.
8
Nandrolone treatment decreases the level of rat kidney alpha(1B)-adrenoceptors.诺龙治疗可降低大鼠肾脏α(1B)-肾上腺素能受体水平。
Naunyn Schmiedebergs Arch Pharmacol. 2003 Aug;368(2):91-8. doi: 10.1007/s00210-003-0763-y. Epub 2003 Jul 12.
9
Tamsulosin: an update of its role in the management of lower urinary tract symptoms.坦索罗辛:其在治疗下尿路症状中作用的最新进展
Drugs. 2002;62(1):135-67. doi: 10.2165/00003495-200262010-00006.
10
Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.坦索罗辛和特拉唑嗪药代动力学的放射受体分析
Br J Clin Pharmacol. 1998 Jan;45(1):49-55. doi: 10.1046/j.1365-2125.1998.00636.x.